Spots Global Cancer Trial Database for EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem

Official Title: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem to Redesign the Suspected Head and Neck Cancer Referral Pathway (Phase 1)

Study ID: NCT05909020

Conditions

Head and Neck Cancer

Interventions

No intervention.

Study Description

Brief Summary: Can a patient-reported symptom-based risk stratification system improve the suspected head and neck cancer (HNC) pathway? Our methodology includes six interlinked work packages to deliver our aim, with EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system.

Detailed Description: The EVEREST-HN pathway should be based on a comprehensive understanding of existing HNC diagnostic pathways and what patients and clinicians value in these. The language used within the EVEREST pathway needs to be accessible and optimal to elicit appropriate information.